|
|
|
Insider
Information: |
Cox John |
Relationship: |
|
City: |
Weston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
44,968 |
|
Indirect Shares
|
4,444 |
|
|
Direct
Value |
$9,357,702 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
49,412 |
|
|
Total
Value |
$9,357,702 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
401.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
EVP Pharmaceutical Ope... |
2016-04-01 |
39,045 |
|
0 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2020-03-24 |
923 |
2015-05-21 |
0 |
Premium* |
|
Bioverativ Inc. |
BIVV |
Chief Executive Office... |
2018-03-08 |
0 |
2017-02-28 |
0 |
Premium* |
|
Sigilon Therapeutics, Inc. |
SGTX |
|
2023-08-11 |
0 |
2020-12-08 |
4,444 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-25 |
5,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2013-05-03 |
4 |
D |
$218.85 |
$189,524 |
D/D |
(866) |
18,060 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2013-02-23 |
4 |
D |
$164.40 |
$201,719 |
D/D |
(1,227) |
18,759 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-03-31 |
4 |
AS |
$73.00 |
$207,320 |
D/D |
(2,840) |
9,818 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2010-10-28 |
4 |
OE |
$33.97 |
$234,393 |
D/D |
6,900 |
25,154 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-11-01 |
4 |
AS |
$114.37 |
$248,755 |
D/D |
(2,175) |
9,588 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-03-02 |
4 |
S |
$70.08 |
$283,259 |
D/D |
(4,041) |
9,818 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2013-02-09 |
4 |
D |
$164.44 |
$301,912 |
D/D |
(1,836) |
17,388 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-04-21 |
4 |
OE |
$72.87 |
$316,985 |
D/D |
4,350 |
14,703 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-04-11 |
4 |
OE |
$47.92 |
$330,648 |
D/D |
6,900 |
17,253 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2016-02-08 |
4 |
D |
$250.77 |
$332,019 |
D/D |
(1,324) |
28,342 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2015-03-25 |
4 |
OE |
$60.56 |
$333,571 |
D/D |
5,066 |
37,577 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2014-02-12 |
4 |
D |
$323.04 |
$342,099 |
D/D |
(1,059) |
24,108 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2016-02-12 |
4 |
D |
$247.22 |
$383,685 |
D/D |
(1,552) |
30,088 |
0 |
- |
|
RGEN |
Repligen Corp |
Director |
|
2020-02-24 |
4 |
S |
$92.76 |
$413,455 |
D/D |
(4,455) |
2,781 |
0 |
% |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2014-02-23 |
4 |
D |
$347.11 |
$426,251 |
D/D |
(1,228) |
25,478 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2010-10-28 |
4 |
AS |
$63.00 |
$434,700 |
D/D |
(6,900) |
18,254 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-04-21 |
4 |
AS |
$100.00 |
$435,000 |
D/D |
(4,350) |
10,353 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2014-02-08 |
4 |
D |
$315.54 |
$454,693 |
D/D |
(1,441) |
20,442 |
0 |
- |
|
BIVV |
Bioverativ Inc. |
Chief Executive Officer |
|
2017-03-31 |
4 |
D |
$54.46 |
$458,335 |
D/D |
(8,416) |
180,632 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2011-04-11 |
4 |
AS |
$78.00 |
$538,200 |
D/D |
(6,900) |
10,353 |
0 |
- |
|
BIVV |
Bioverativ Inc. |
Chief Executive Officer |
|
2018-02-23 |
4 |
D |
$104.74 |
$606,864 |
D/D |
(5,794) |
185,094 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2015-02-08 |
4 |
D |
$402.00 |
$617,874 |
D/D |
(1,537) |
28,053 |
0 |
- |
|
RGEN |
Repligen Corp |
Director |
|
2020-03-18 |
4 |
OE |
$12.91 |
$651,603 |
D/D |
26,736 |
29,517 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2015-02-12 |
4 |
D |
$392.11 |
$690,506 |
D/D |
(1,761) |
32,511 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
|
2014-02-09 |
4 |
D |
$315.54 |
$697,974 |
D/D |
(2,212) |
22,921 |
0 |
- |
|
85 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|